Investing Profile

Peter Bisgaard

InvestorVC
Managing Director at Pivotal bioVenture Partners
pivotalbiovp.com/team-members...San Francisco Bay Area
Photo of Peter Bisgaard, Managing Director at Pivotal bioVenture Partners
Your Intro Paths to Peter Bisgaard

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Peter Bisgaard on

cb
Current Investing Position
Pivotal bioVenture Partners Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11
Current Fund Size
$300M

Peter Bisgaard is on these Sector & Stage Rankings

Peter Bisgaard's Investments On Record (7)

CompanyStageDateRound SizeTotal Raised
Engrail Therapeutics
Series BMar 2024$160M
$160M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Ceterix Orthopaedics
Series BMay 2014$18M
$18M
Co-investors: Charles Warden (Versant Ventures)
Otonomy
Series DApr 2014$49M
Series CSep 2013$46M
Series BAug 2010$39M
Series BAug 2010$39M
$180M
Co-investors: Chau Khuong (OrbiMed), John McKearn (RiverVest), Jay Lichter (Avalon Ventures), Bill Harrington (Osage University Partners), Brian Dovey (Domain Associates), Niall O’Donnell (RiverVest), Heather Preston
Nevro
Series CMar 2013$48M
$130M
Co-investors: Paul Klingenstein (Aberdare Ventures), Asish Xavier (Johnson & Johnson Innovation)
Alder Biopharmaceuticals
Series DApr 2012$38M
$78M
Co-investors: Heather Preston
Altheos
Series AFeb 2012$13M
Series AApr 2010$20M
$33M
Co-investors: Wende Hutton (Canaan Partners)
Light Sciences Oncology
Series ADec 2005$32M
$32M

Peter Bisgaard's Experience

Managing Director Nan Fung Life Sciences2017 - Present